Tsfg, LLC Bio N Tech Se Transaction History

Tsfg, LLC

$489 Million
Q1 2025

A detailed history of Tsfg, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Tsfg, LLC holds 178 shares of BNTX stock, worth $17,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178

Previous 178 -0.0%

Holding current value

$17,565

Previous $20,000 20.0%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$127.65 - $183.11 $10,212 - $14,648	-80 Reduced 31.01%	178 $24,000
Q1 2022 Apr 25, 2022	SELL	$126.25 - $231.85 $4,797 - $8,810	-38 Reduced 12.84%	258 $44,000
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $4,766 - $7,975	-22 Reduced 6.92%	296 $76,000
Q4 2020 Jan 20, 2021	BUY	$72.71 - $129.54 $5,816 - $10,363	80 Added 33.61%	318 $26,000
Q3 2020 Oct 06, 2020	BUY	$57.81 - $104.17 $11,562 - $20,834	200 Added 526.32%	238 $16,000
Q2 2020 Jul 07, 2020	BUY	$38.58 - $66.74 $1,466 - $2,536	38 New	38 $3,000

Others Institutions Holding BNTX

# of Institutions

340

Shares Held

40M

Call Options Held

1.43M

Put Options Held

1.54M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $23.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account